217 related articles for article (PubMed ID: 20177885)
1. Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.
Tripathi NK; Shukla J; Biswal KC; Lakshmana Rao PV
Appl Microbiol Biotechnol; 2010 May; 86(6):1795-803. PubMed ID: 20177885
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of recombinant dengue virus type 4 envelope domain III protein.
Tripathi NK; Babu JP; Shrivastva A; Parida M; Jana AM; Rao PV
J Biotechnol; 2008 Apr; 134(3-4):278-86. PubMed ID: 18342971
[TBL] [Abstract][Full Text] [Related]
3. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.
Tripathi NK; Shrivastava A; Biswal KC; Rao PV
Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895
[TBL] [Abstract][Full Text] [Related]
4. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
Jaiswal S; Khanna N; Swaminathan S
Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
[TBL] [Abstract][Full Text] [Related]
5. Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.
Tripathi NK; Shrivastava A; Biswal KC; Rao PV
Appl Microbiol Biotechnol; 2012 Sep; 95(5):1179-89. PubMed ID: 22562165
[TBL] [Abstract][Full Text] [Related]
6. Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coli.
Tripathi NK; Priya R; Shrivastava A
Appl Microbiol Biotechnol; 2014 Mar; 98(6):2461-71. PubMed ID: 24337252
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of domain III of the envelope gene of Japanese encephalitis virus: evaluation for early clinical diagnosis by IgM ELISA.
Shukla J; Bhargava R; Dash PK; Parida M; Tripathi N; Rao PV
J Virol Methods; 2009 Jun; 158(1-2):165-70. PubMed ID: 19428586
[TBL] [Abstract][Full Text] [Related]
8. Production of recombinant nonstructural 1 protein in Escherichia coli for early detection of Japanese encephalitis virus infection.
Tripathi NK; Kumar JS; Biswal KC; Rao PV
Microb Biotechnol; 2012 Sep; 5(5):599-606. PubMed ID: 22452851
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis.
Konishi E; Mason PW; Shope RE
J Med Virol; 1996 Jan; 48(1):76-9. PubMed ID: 8825714
[TBL] [Abstract][Full Text] [Related]
10. Development of a simple fed-batch process for the high-yield production of recombinant shiga toxin B-chain protein.
Sharma K; Gupta P; Kumar Singh A; Gopalan N; Kumar Dhaked R; Lakshmana Rao PV
Protein Pept Lett; 2012 Feb; 19(2):228-37. PubMed ID: 21838697
[TBL] [Abstract][Full Text] [Related]
11. Development of the second generation Japanese encephalitis (JE) vaccine.
Igarashi A
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):493-500. PubMed ID: 3217827
[TBL] [Abstract][Full Text] [Related]
12. Production of IgM specific recombinant dengue multiepitope protein for early diagnosis of dengue infection.
Tripathi NK; Shrivastva A; Pattnaik P; Parida M; Dash PK; Gupta N; Jana AM; Rao PV
Biotechnol Prog; 2007; 23(2):488-93. PubMed ID: 17256968
[TBL] [Abstract][Full Text] [Related]
13. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
[TBL] [Abstract][Full Text] [Related]
14. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].
Shin CS; Hong MS; Bae CS; Lee J
Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone.
Mutoh E; Ishikawa T; Takamizawa A; Kurata T; Sata T; Kojima A
Vaccine; 2004 Jun; 22(20):2599-608. PubMed ID: 15193385
[TBL] [Abstract][Full Text] [Related]
16. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
[TBL] [Abstract][Full Text] [Related]
17. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III].
Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W
Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of Japanese encephalitis virus envelope protein gene from swine.
Fan JM; Luo J; Zhang GP; Chen L; Teng M; Yang MF; Wang L; Wang CQ
Lett Appl Microbiol; 2010 Jul; 51(1):11-7. PubMed ID: 20477964
[TBL] [Abstract][Full Text] [Related]
19. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
